SCHEMBL21614656

SCHEMBL21614656

CC(C)Oc1ccc(-c2ncc(CNc3ccnc(C(F)(F)F)c3)cn2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 5/20 0.52
▸ CYP2C9 P11712 3/20 0.52
▸ USP1 O94782 1/20 0.41
▸ WDR48 Q8TAF3 1/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ CYP1A2 P05177 3/20 0.40
▸ VNN1 O95497 1/20 0.39
▸ HDAC6 Q9UBN7 2/20 0.37
▸ HDAC4 P56524 1/20 0.37
▸ MGLL Q99685 3/20 0.37
▸ ADAMTS4 O75173 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ F2 P00734 1/20 0.37
▸ PRSS1 P07477 1/20 0.37
▸ TP53 P04637 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21614646 0.85 CYP2C19 (0.70) CYP2C19CYP2C9USP1WDR48CYP3A4
SCHEMBL21611930 0.85 CYP2C9 (0.42) CYP2C19CYP2C9CYP3A4CYP1A2HDAC6
SCHEMBL21614661 0.84 CYP2C19 (0.57) CYP2C19CYP2C9USP1WDR48CYP3A4
SCHEMBL21611949 0.83 CYP2C19 (0.55) CYP2C19CYP2C9USP1WDR48CYP3A4
SCHEMBL21614772 0.82 CYP2C19 (0.75) CYP2C19CYP2C9USP1WDR48CYP3A4
SCHEMBL23611516 0.81 MAPT (0.38) CYP2C19CYP2C9CYP3A4CYP1A2TP53
SCHEMBL30060488 0.81 MAPT (0.38) CYP2C19CYP2C9CYP3A4CYP1A2TP53
SCHEMBL23611396 0.80 KDM4E (0.42) CYP2C19CYP2C9USP1WDR48CYP3A4
SCHEMBL21614721 0.80 CYP2C19 (0.51) CYP2C19CYP2C9CYP3A4CYP1A2TP53
SCHEMBL23611417 0.79 MAPT (0.37) CYP2C19CYP2C9CYP3A4CYP1A2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed
WO-2020007938-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2020-01-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 CYP2C19 1824/4885CYP2C9 2997/4885USP1 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback